SIM
CNTA

Sandia Investment Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Sandia Investment Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,000
Closed -$80K – 125
2024
Q3 		$80K Sell
5,000
-5,000
-50% -$61.3K 0.13% 79
2024
Q2 		$90.3K Buy
+10,000
New +$94.8K 0.11% 80

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sandia Investment Management's CNTA Position: Q4 2024 in Review

Sandia Investment Management sold out of Centessa Pharmaceuticals (CNTA) in Q4 2024, closing a stake of 5,000 shares — an estimated $80K sold.

Sandia Investment Management first reported a position in CNTA in Q2 2024 and held it in 2 quarters. The position peaked at $90.3K in Q2 2024. 114 funds tracked by Wall St. Rank hold CNTA as of Q4 2024.

  • Sandia Investment Management reported no remaining Centessa Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Sandia Investment Management sold 5,000 Centessa Pharmaceuticals shares in Q4 2024, an estimated $80K.
  • Sandia Investment Management first reported a position in Centessa Pharmaceuticals in Q2 2024 and held it in 2 quarters.
  • Sandia Investment Management's Centessa Pharmaceuticals position peaked at $90.3K in Q2 2024.
  • 114 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2024.

Based on Sandia Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.